DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Mitchell TW Tracking the glycerophospholipid distribution of docosahexaenoic acid by shotgun lipidomics. 2009 Methods Mol. Biol. pmid:19763469
Wu GS and Rao NA Detection of docosahexaenoic acid hydroperoxides in retina by gas chromatography/mass spectrometry. 2002 Methods Mol. Biol. pmid:12013778
Chiang N and Serhan CN Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. 2006 Methods Mol. Biol. pmid:16799203
Kafanova TV et al. [Marine fungus Stilbella aciculosa as a potential producer of prostaglandins]. 2008 Jul-Aug Mikrobiologiia pmid:18825978
Nordøy A Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease. 2002 Minerva Med. pmid:12410168
Leggieri E et al. Clinical effects of diet supplementation with DHA in pediatric patients suffering from cystic fibrosis. 2013 Minerva Pediatr. pmid:24051972
Amann-Gassner U and Hastreiter L [Nutrition during pregnancy]. 2012 MMW Fortschr Med pmid:22352251
[Start of insulin therapy. How to ensure patient compliance?]. 2006 MMW Fortschr Med pmid:16995354
[Additional omega-3-fatty acids. Infarct mortality gets reduced]. 2003 MMW Fortschr Med pmid:12688033
[Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester]. 2005 MMW Fortschr Med pmid:16302427
von Schacky C [Omega-3 fatty acids in cardiology. Latest developments]. 2007 MMW Fortschr Med pmid:17955786
[Sudden cardiac death. Targets every 2nd person without warning]. 2003 MMW Fortschr Med pmid:12619216
Kreutzkamp B [Therapy of atopic eczema in the new light. When the skin barrier is not firm]. 2008 MMW Fortschr Med pmid:18361139
Si TL et al. Enhanced anti-inflammatory effects of DHA and quercetin in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPK activation. 2016 Mol Med Rep pmid:27176922
Yao C et al. Neuroprotectin D1 attenuates brain damage induced by transient middle cerebral artery occlusion in rats through TRPC6/CREB pathways. 2013 Mol Med Rep pmid:23799606
Yao QH et al. ω-3 polyunsaturated fatty acids inhibit the proliferation of the lung adenocarcinoma cell line A549 in vitro. 2014 Mol Med Rep pmid:24276408
Greener M Fatty acid imbalance might lead to novel treatments for CF. 2000 Mol Med Today pmid:10652475
Jackson KG et al. Dietary fat manipulation has a greater impact on postprandial lipid metabolism than the apolipoprotein E (epsilon) genotype-insights from the SATgenε study. 2012 Mol Nutr Food Res pmid:23097177
Maskrey BH et al. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis. 2013 Mol Nutr Food Res pmid:23417926
Lu CY et al. Docosahexaenoic acid downregulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the c-Jun NH2-terminal kinase mitogen-activated protein kinase pathway. 2009 Mol Nutr Food Res pmid:18803253
Zlatanos S et al. Proximate composition, fatty acid analysis and protein digestibility-corrected amino acid score of three Mediterranean cephalopods. 2006 Mol Nutr Food Res pmid:17009215
Kim HJ et al. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice. 2008 Mol Nutr Food Res pmid:18481331
Lundström SL et al. Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids. 2013 Mol Nutr Food Res pmid:23824870
Li JJ et al. Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. 2008 Mol Nutr Food Res pmid:18306430
Rudkowska I et al. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity. 2010 Mol Nutr Food Res pmid:19937854
Yee LD et al. The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. 2013 Mol Nutr Food Res pmid:23213007
Xiong A et al. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. 2012 Mol Nutr Food Res pmid:22707267
Barbadoro P et al. Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics. 2013 Mol Nutr Food Res pmid:23390041
Cho JY et al. Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice. 2011 Mol Nutr Food Res pmid:20824662
Wielinga PY et al. Arachidonic acid/docosahexaenoic acid-supplemented diet in early life reduces body weight gain, plasma lipids, and adiposity in later life in ApoE*3Leiden mice. 2012 Mol Nutr Food Res pmid:22611002
Huang CB and Ebersole JL A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives. 2010 Mol Oral Microbiol pmid:20331795
Sun C et al. DHA regulates lipogenesis and lipolysis genes in mice adipose and liver. 2011 Mol. Biol. Rep. pmid:20383747
Gelsomino G et al. Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. 2013 Mol. Cancer pmid:24225025
Altenburg JD and Siddiqui RA Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. 2009 Mol. Cancer Res. pmid:19567784
Ding WQ et al. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. 2004 Mol. Cancer Ther. pmid:15367705
Swamy MV et al. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. 2004 Mol. Cancer Ther. pmid:14985462
Ding WQ and Lind SE Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. 2007 Mol. Cancer Ther. pmid:17431126
Ding WQ et al. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. 2006 Mol. Cancer Ther. pmid:16891473
Lim K et al. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. 2009 Mol. Cancer Ther. pmid:19887546
Lengqvist J et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. 2004 Mol. Cell Proteomics pmid:15073272
Zand H et al. Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells. 2007 Mol. Cell. Biochem. pmid:17487454
Wang TM et al. Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells. 2013 Mol. Cell. Biochem. pmid:23361365
Crabtree JT et al. Differential distribution and metabolism of arachidonic acid and docosahexaenoic acid by human placental choriocarcinoma (BeWo) cells. 1998 Mol. Cell. Biochem. pmid:9746226
Rousseau D et al. Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats. 2001 Mol. Cell. Biochem. pmid:11716352
Hashimoto M et al. Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity. 2006 Mol. Cell. Biochem. pmid:16933035
Grynberg A et al. Eicosapentaenoic and docosahexaenoic acids in cultured rat ventricular myocytes and hypoxia-induced alterations of phospholipase-A activity. 1992 Mol. Cell. Biochem. pmid:1480156
Ishigamori H et al. Docosahexaenoic acid-containing phosphatidylethanolamine enhances HL-60 cell differentiation by regulation of c-jun and c-myc expression. 2005 Mol. Cell. Biochem. pmid:16335792
Palacios A et al. Antioxidant effect of conjugated linoleic acid and vitamin A during non enzymatic lipid peroxidation of rat liver microsomes and mitochondria. 2003 Mol. Cell. Biochem. pmid:12962148
Hossain Z et al. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells. 2006 Mol. Cell. Biochem. pmid:16477371
Zand H et al. Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression. 2008 Mol. Cell. Biochem. pmid:18566752
Sugasini D and Lokesh BR Enhanced incorporation of docosahexaenoic acid in serum, heart, and brain of rats given microemulsions of fish oil. 2013 Mol. Cell. Biochem. pmid:23812902
Azordegan N et al. Carcinogenesis alters fatty acid profile in breast tissue. 2013 Mol. Cell. Biochem. pmid:23180247
Shaikh NA et al. Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial. 2014 Mol. Cell. Biochem. pmid:25185754
Rousseau D et al. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress? 1998 Mol. Cell. Biochem. pmid:9546620
Infante JP and Huszagh VA On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. 1997 Mol. Cell. Biochem. pmid:9062899
Infante JP Docosahexaenoate-containing phospholipids in sarcoplasmic reticulum and retinal photoreceptors. A proposal for a role in Ca2+-ATPase calcium transport. 1987 Mol. Cell. Biochem. pmid:2955214
Murphy MG et al. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart. 1997 Mol. Cell. Biochem. pmid:9450671
Jahangiri A et al. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. 2000 Mol. Cell. Biochem. pmid:10839192
Durot I et al. Influence of phospholipid long chain polyunsaturated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and during glucose-free hypoxia-reoxygenation. 1997 Mol. Cell. Biochem. pmid:9350058
Denys A et al. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. 2002 Mol. Cell. Biochem. pmid:12030372
Cooke M et al. Expression and function of OXE receptor, an eicosanoid receptor, in steroidogenic cells. 2013 Mol. Cell. Endocrinol. pmid:23159987
Tran DQ et al. Induction of Gnrh mRNA expression by the ω-3 polyunsaturated fatty acid docosahexaenoic acid and the saturated fatty acid palmitate in a GnRH-synthesizing neuronal cell model, mHypoA-GnRH/GFP. 2016 Mol. Cell. Endocrinol. pmid:26923440
Egea PF et al. Molecular recognition of agonist ligands by RXRs. 2002 Mol. Endocrinol. pmid:11981034
Infante JP and Huszagh VA Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. 2001 Mol. Genet. Metab. pmid:11243724
Infante JP and Huszagh VA Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis. 2001 Mol. Genet. Metab. pmid:11161822
Jans JJ et al. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU. 2013 Mol. Genet. Metab. pmid:23562298
Fabelo N et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. 2011 Sep-Oct Mol. Med. pmid:21717034
Frautschy SA and Cole GM Why pleiotropic interventions are needed for Alzheimer's disease. 2010 Mol. Neurobiol. pmid:20437209
Lukiw WJ and Bazan NG Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis. 2010 Mol. Neurobiol. pmid:20414817
Palacios-Pelaez R et al. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. 2010 Mol. Neurobiol. pmid:20467837
Bazan NG et al. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. 2011 Mol. Neurobiol. pmid:21918832
Stark DT and Bazan NG Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models. 2011 Mol. Neurobiol. pmid:21431475
Bazan NG Neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1. 2012 Mol. Neurobiol. pmid:22956271
Hollyfield JG et al. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. 2010 Mol. Neurobiol. pmid:20221855
Picq M et al. DHA metabolism: targeting the brain and lipoxygenation. 2010 Mol. Neurobiol. pmid:20422316
Wang H et al. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. 2010 Mol. Pharm. pmid:20831192
Lin DC et al. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor. 2012 Mol. Pharmacol. pmid:22859723
Tuller ER et al. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. 2009 Mol. Pharmacol. pmid:19528198
Sharma NP et al. Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. 2010 Mol. Pharmacol. pmid:20194532
Calderaro V et al. Docosahexaenoic acid and signaling pathways in rabbit colon. 1994 Mol. Pharmacol. pmid:8183254
Aires V et al. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. 2007 Mol. Pharmacol. pmid:17878267
Nakano M et al. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. 2012 Mol. Pharmacol. pmid:22772592
Poling JS et al. Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. 1995 Mol. Pharmacol. pmid:7870048
Seung Kim HF et al. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. 2001 Mol. Psychiatry pmid:11317232
Rao JS et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. 2007 Mol. Psychiatry pmid:16983391
Rao JS et al. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. 2007 Mol. Psychiatry pmid:16983392
Ollero M et al. Variation of docosahexaenoic acid content in subsets of human spermatozoa at different stages of maturation: implications for sperm lipoperoxidative damage. 2000 Mol. Reprod. Dev. pmid:10657052
Anderson RE et al. Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. 2002 Mol. Vis. pmid:12355064
Li F et al. DHA does not protect ELOVL4 transgenic mice from retinal degeneration. 2009 Mol. Vis. pmid:19536303
Gross EA et al. G239T mutation in Repeat 1 of human IRBP: possible implications for more than one binding site in a single repeat. 2000 Mol. Vis. pmid:10756181
Sheets KG et al. Microglial ramification and redistribution concomitant with the attenuation of choroidal neovascularization by neuroprotectin D1. 2013 Mol. Vis. pmid:23922492
Sheets KG et al. Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. 2010 Mol. Vis. pmid:20216940
Li F et al. High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice. 2010 Mol. Vis. pmid:20806040
Katakura M et al. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. 2014 Molecules pmid:24642910
Lau BY et al. Investigating the role of polyunsaturated fatty acids in bone development using animal models. 2013 Molecules pmid:24248147
Vasantha Rupasinghe HP and Yasmin A Inhibition of oxidation of aqueous emulsions of omega-3 fatty acids and fish oil by phloretin and phloridzin. 2010 Molecules pmid:20110888
Abdulnour RE et al. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. 2016 Mucosal Immunol pmid:26647716
Arnardottir H et al. Human milk proresolving mediators stimulate resolution of acute inflammation. 2016 Mucosal Immunol pmid:26462421
Eickmeier O et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. 2013 Mucosal Immunol pmid:22785226
Li D et al. Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. 2013 Mucosal Immunol pmid:23462912